pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3179-1 |
Genomic Coordinates | chr16: 14901508 - 14901591 |
Description | Homo sapiens miR-3179-1 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-3179-2 |
Genomic Coordinates | chr16: 16300159 - 16300242 |
Description | Homo sapiens miR-3179-2 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-3179-3 |
Genomic Coordinates | chr16: 18411894 - 18411977 |
Description | Homo sapiens miR-3179-3 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases | |
pre-miRNA | hsa-mir-3179-4 |
Genomic Coordinates | chr16: 18494493 - 18494576 |
Description | Homo sapiens miR-3179-4 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3179 | |||||||||||||||
Sequence | 52| AGAAGGGGUGAAAUUUAAACGU |73 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BTG2 | ||||||||||||||||||||
Synonyms | APRO1, PC3, TIS21 | ||||||||||||||||||||
Description | BTG anti-proliferation factor 2 | ||||||||||||||||||||
Transcript | NM_006763 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on BTG2 | |||||||||||||||||||||
3'UTR of BTG2 (miRNA target sites are highlighted) |
>BTG2|NM_006763|3'UTR 1 GCCCTTCCGCCCCCGCCCTGGGCGCCGCCGTGCTCATGCTGCCGTGACAACAGGCCACCACATACCTCAACCTGGGGAAC 81 TGTATTTTTAAATGAAGAGCTATTTATATATATTATTTTTTTTTAAGAAAGGAGGAAAAGAAACCAAAAGTTTTTTTTAA 161 GAAAAAAAATCCTTCAAGGGAGCTGCTTGGAAGTGGCCTCCCCAGGTGCCTTTGGAGAGAACTGTTGCGTGCTTGAGTCT 241 GTGAGCCAGTGTCTGCCTATAGGAGGGGGAGCTGTTAGGGGGTAGACCTAGCCAAGGAGAAGTGGGAGACGTTTGGCTAG 321 CACCCCAGGAAGATGTGAGAGGGAGCAAGCAAGGTTAGCAACTGTGAACAGAGAGGTCGGGATTTGCCCTGGGGGAGGAA 401 GAGAGGCCAAGTTCAGAGCTCTCTGTCTCCCCCAGCCAGACACCTGCATCCCTGGCTCCTCTATTACTCAGGGGCATTCA 481 TGCCTGGACTTAAACAATACTATGTTATCTTTTCTTTTATTTTTCTAATGAGGTCCTGGGCAGAGAGTGAAAAGGCCTCT 561 CCTGATTCCTACTGTCCTAAGCTGCTTTTCTTGAAATCATGACTTGTTTCTAATTCTACCCTCAGGGGCCTGTAGATGTT 641 GCTTTCCAGCCAGGAATCTAAAGCTTTGGGTTTTCTGAGGGGGGGGAGGAGGGAACTGGAGGTTATTGGGGTTAGGATGG 721 AAGGGAACTCTGCACAAAACCTTTGCTTTGCTAGTGCTGCTTTGTGTGTATGTGTGGCAAATAATTTGGGGGTGATTTGC 801 AATGAAATTTTGGGACCCAAAGAGTATCCACTGGGGATGTTTTTTGGCCAAAACTCTTCCTTTTGGAACCACATGAAAGT 881 CTTGATGCTGCTGCCATGATCCCTTTGAGAGGTGGCTCAAAAGCTACAGGGAACTCCAGGTCCTTTATTACTGCCTTCTT 961 TTCAAAAGCACAACTCTCCTCTAACCCTCCCCTCCCCCTTCCCTTCTGGTCGGGTCATAGAGCTACCGTATTTTCTAGGA 1041 CAAGAGTTCTCAGTCACTGTGCAATATGCCCCCTGGGTCCCAGGAGGGTCTGGAGGAAAACTGGCTATCAGAACCTCCTG 1121 ATGCCCTGGTGGGCTTAGGGAACCATCTCTCCTGCTCTCCTTGGGATGATGGCTGGCTAGTCAGCCTTGCATGTATTCCT 1201 TGGCTGAATGGGAGAGTGCCCCATGTTCTGCAAGACTACTTGGTATTCTTGTAGGGCCGACACTAAATAAAAGCCAAACC 1281 TTGGGCACTGTTTTTTCTCCCTGGTGCTCAGAGCACCTGTGGGAAAGGTTGCTGTCTGTCTCAGTACAATCCAAATTTGT 1361 CGTAGACTTGTGCAATATATACTGTTGTGGGTTGGAGAAAAGTGGAAAGCTACACTGGGAAGAAACTCCCTTCCTTCAAT 1441 TTCTCAGTGACATTGATGAGGGGTCCTCAAAAGACCTCGAGTTTCCCAAACCGAATCACCTTAAGAAGGACAGGGCTAGG 1521 GCATTTGGCCAGGATGGCCACCCTCCTGCTGTTGCCCCTTAGTGAGGAATCTTCACCCCACTTCCTCTACCCCCAGGTTC 1601 TCCTCCCCACAGCCAGTCCCCTTTCCTGGATTTCTAAACTGCTCAATTTTGACTCAAAGGTGCTATTTACCAAACACTCT 1681 CCCTACCCATTCCTGCCAGCTCTGCCTCCTTTTCAACTCTCCACATTTTGTATTGCCTTCCCAGACCTGCTTCCAGTCTT 1761 TATTGCTTTAAAGTTCACTTTGGGCCCACAGACCCAAGAGCTAATTTTCTGGTTTGTGGGTTGAAACAAAGCTGTGAATC 1841 ACTGCAGGCTGTGTTCTTGCATCTTGTCTGCAAACAGGTCCCTGCCTTTTTAGAAGCAGCCTCATGGTCTCATGCTTAAT 1921 CTTGTCTCTCTTCTCTTCTTTATGATGTTCACTTTAAAAACAACAAAACCCCTGAGCTGGACTGTTGAGCAGGCCTGTCT 2001 CTCCTATTAAGTAAAAATAAATAGTAGTAGTATGTTTGTAAGCTATTCTGACAGAAAAGACAAAGGTTACTAATTGTATG 2081 ATAGTGTTTTTATATGGAAGAATGTACAGCTTATGGACAAATGTACACCTTTTTGTTACTTTAATAAAAATGTAGTAGGA 2161 TAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177611. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_1
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Prostate Tissue |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760597. RNA binding protein: AGO2. Condition:AGO-CLIP-LNCaP_C
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_006763 | 3UTR | AAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_006763 | 3UTR | GCUGCUGCCAUGAUCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_006763 | 3UTR | UCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_006763 | 3UTR | UGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_006763 | 3UTR | UCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_006763 | 3UTR | UGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_006763 | 3UTR | AUCCCUUUGAGAGGUGGCUCAAAAGCUACAGGGAACUCCAGGUCCUUUAUUACUGCCUUCUUUUCAAAAGCACAACUCUCCUCUAACCCUCCCCUCCCCCUUCCCUUCUGGUCGGGUCAUAGAGCUACCGUAUUUUCUAGGACAAGAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000290551.4 | 3UTR | UCUAACCCUCCCCUCCCCCUUCCCUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
133 hsa-miR-3179 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT102087 | GIGYF1 | GRB10 interacting GYF protein 1 | 2 | 4 | ||||||||
MIRT110061 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | 2 | 6 | ||||||||
MIRT112198 | BTG2 | BTG anti-proliferation factor 2 | 2 | 2 | ||||||||
MIRT117668 | SCAMP4 | secretory carrier membrane protein 4 | 2 | 2 | ||||||||
MIRT146657 | MINK1 | misshapen like kinase 1 | 2 | 2 | ||||||||
MIRT175505 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 4 | ||||||||
MIRT180535 | TXNIP | thioredoxin interacting protein | 2 | 2 | ||||||||
MIRT190624 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | 2 | 2 | ||||||||
MIRT190650 | PABPN1 | poly(A) binding protein nuclear 1 | 2 | 2 | ||||||||
MIRT366902 | NONO | non-POU domain containing octamer binding | 2 | 2 | ||||||||
MIRT443554 | ZFP3 | ZFP3 zinc finger protein | 2 | 2 | ||||||||
MIRT445953 | MLLT11 | MLLT11, transcription factor 7 cofactor | 2 | 2 | ||||||||
MIRT446042 | HMCN1 | hemicentin 1 | 2 | 2 | ||||||||
MIRT447968 | MSH6 | mutS homolog 6 | 2 | 2 | ||||||||
MIRT448634 | ONECUT1 | one cut homeobox 1 | 2 | 2 | ||||||||
MIRT449316 | MRO | maestro | 2 | 2 | ||||||||
MIRT451380 | C19orf43 | telomerase RNA component interacting RNase | 2 | 2 | ||||||||
MIRT451547 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | 2 | 2 | ||||||||
MIRT451807 | CDCA3 | cell division cycle associated 3 | 2 | 4 | ||||||||
MIRT451916 | ILK | integrin linked kinase | 2 | 2 | ||||||||
MIRT451938 | TMPRSS5 | transmembrane protease, serine 5 | 2 | 2 | ||||||||
MIRT452189 | KIAA1456 | KIAA1456 | 2 | 2 | ||||||||
MIRT452498 | HMGXB3 | HMG-box containing 3 | 2 | 2 | ||||||||
MIRT452548 | ZNF467 | zinc finger protein 467 | 2 | 2 | ||||||||
MIRT453844 | SDK1 | sidekick cell adhesion molecule 1 | 2 | 2 | ||||||||
MIRT454515 | ZFYVE27 | zinc finger FYVE-type containing 27 | 2 | 2 | ||||||||
MIRT455363 | KDM5C | lysine demethylase 5C | 2 | 2 | ||||||||
MIRT455455 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | 2 | 2 | ||||||||
MIRT455628 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | 2 | 10 | ||||||||
MIRT455639 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | 2 | 10 | ||||||||
MIRT455690 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT456300 | ASH1L | ASH1 like histone lysine methyltransferase | 2 | 2 | ||||||||
MIRT456784 | MTHFSD | methenyltetrahydrofolate synthetase domain containing | 2 | 2 | ||||||||
MIRT456819 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | 2 | 2 | ||||||||
MIRT457566 | ZNF34 | zinc finger protein 34 | 2 | 2 | ||||||||
MIRT457604 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT458236 | NXPH3 | neurexophilin 3 | 2 | 2 | ||||||||
MIRT458313 | TNFAIP8L3 | TNF alpha induced protein 8 like 3 | 2 | 2 | ||||||||
MIRT458350 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | 2 | 2 | ||||||||
MIRT458670 | GPR35 | G protein-coupled receptor 35 | 2 | 2 | ||||||||
MIRT459675 | VPS37C | VPS37C, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT461126 | RAB36 | RAB36, member RAS oncogene family | 2 | 2 | ||||||||
MIRT461918 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | 2 | 2 | ||||||||
MIRT462301 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | 2 | 2 | ||||||||
MIRT463520 | ZBTB7B | zinc finger and BTB domain containing 7B | 2 | 2 | ||||||||
MIRT464378 | URM1 | ubiquitin related modifier 1 | 2 | 2 | ||||||||
MIRT464614 | UBE4B | ubiquitination factor E4B | 2 | 2 | ||||||||
MIRT464711 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT465520 | PRICKLE4 | prickle planar cell polarity protein 4 | 2 | 2 | ||||||||
MIRT465974 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466058 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT466548 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | 2 | 2 | ||||||||
MIRT466647 | TAGLN2 | transgelin 2 | 2 | 2 | ||||||||
MIRT467357 | SP2 | Sp2 transcription factor | 2 | 2 | ||||||||
MIRT468744 | SDC2 | syndecan 2 | 2 | 2 | ||||||||
MIRT470244 | PRRC2A | proline rich coiled-coil 2A | 2 | 2 | ||||||||
MIRT471426 | PDIA6 | protein disulfide isomerase family A member 6 | 2 | 2 | ||||||||
MIRT471732 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | 2 | 2 | ||||||||
MIRT472190 | NHP2L1 | small nuclear ribonucleoprotein 13 | 2 | 2 | ||||||||
MIRT472450 | NAV2 | neuron navigator 2 | 2 | 6 | ||||||||
MIRT474563 | KLHDC3 | kelch domain containing 3 | 2 | 2 | ||||||||
MIRT474936 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 2 | ||||||||
MIRT475165 | IP6K1 | inositol hexakisphosphate kinase 1 | 2 | 2 | ||||||||
MIRT475399 | ICMT | isoprenylcysteine carboxyl methyltransferase | 2 | 4 | ||||||||
MIRT475426 | ICK | intestinal cell kinase | 2 | 2 | ||||||||
MIRT477090 | FAM168A | family with sequence similarity 168 member A | 2 | 2 | ||||||||
MIRT478458 | DAB2 | DAB2, clathrin adaptor protein | 2 | 2 | ||||||||
MIRT478953 | COX15 | COX15, cytochrome c oxidase assembly homolog | 2 | 2 | ||||||||
MIRT480096 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT481924 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT483217 | APOA1 | apolipoprotein A1 | 2 | 6 | ||||||||
MIRT483882 | TGIF1 | TGFB induced factor homeobox 1 | 2 | 2 | ||||||||
MIRT483923 | SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 2 | 2 | ||||||||
MIRT483942 | LENG8 | leukocyte receptor cluster member 8 | 2 | 4 | ||||||||
MIRT484209 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 2 | ||||||||
MIRT484512 | SYT7 | synaptotagmin 7 | 2 | 2 | ||||||||
MIRT484709 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT485356 | MYO1C | myosin IC | 2 | 4 | ||||||||
MIRT485615 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | 2 | 4 | ||||||||
MIRT486584 | ZNF619 | zinc finger protein 619 | 2 | 2 | ||||||||
MIRT487013 | C2orf82 | chromosome 2 open reading frame 82 | 2 | 2 | ||||||||
MIRT487621 | C20orf96 | chromosome 20 open reading frame 96 | 2 | 2 | ||||||||
MIRT487801 | GPR20 | G protein-coupled receptor 20 | 2 | 4 | ||||||||
MIRT488134 | GPR107 | G protein-coupled receptor 107 | 2 | 2 | ||||||||
MIRT488773 | FXYD1 | FXYD domain containing ion transport regulator 1 | 2 | 2 | ||||||||
MIRT488854 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT489783 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | 2 | 2 | ||||||||
MIRT490102 | FN3K | fructosamine 3 kinase | 2 | 2 | ||||||||
MIRT490389 | LHFPL3 | LHFPL tetraspan subfamily member 3 | 2 | 2 | ||||||||
MIRT490434 | MYL9 | myosin light chain 9 | 2 | 2 | ||||||||
MIRT490451 | GLUD1 | glutamate dehydrogenase 1 | 2 | 2 | ||||||||
MIRT490880 | OSBP | oxysterol binding protein | 2 | 2 | ||||||||
MIRT491037 | ALPK3 | alpha kinase 3 | 2 | 2 | ||||||||
MIRT491250 | HCN2 | hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | 2 | 2 | ||||||||
MIRT491748 | SEMA3F | semaphorin 3F | 2 | 2 | ||||||||
MIRT492235 | SLC48A1 | solute carrier family 48 member 1 | 2 | 2 | ||||||||
MIRT492490 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | 2 | 2 | ||||||||
MIRT492505 | RANBP10 | RAN binding protein 10 | 2 | 4 | ||||||||
MIRT492773 | PDGFB | platelet derived growth factor subunit B | 2 | 2 | ||||||||
MIRT492922 | NFAT5 | nuclear factor of activated T-cells 5 | 2 | 2 | ||||||||
MIRT493459 | ITFG3 | family with sequence similarity 234 member A | 2 | 2 | ||||||||
MIRT493654 | HDLBP | high density lipoprotein binding protein | 2 | 2 | ||||||||
MIRT494011 | DUSP9 | dual specificity phosphatase 9 | 2 | 2 | ||||||||
MIRT499412 | PLCG2 | phospholipase C gamma 2 | 2 | 4 | ||||||||
MIRT499552 | C15orf43 | telomere repeat binding bouquet formation protein 2 | 2 | 2 | ||||||||
MIRT501836 | NCOA2 | nuclear receptor coactivator 2 | 2 | 2 | ||||||||
MIRT501950 | MAT2A | methionine adenosyltransferase 2A | 2 | 10 | ||||||||
MIRT504066 | KCTD12 | potassium channel tetramerization domain containing 12 | 2 | 4 | ||||||||
MIRT504509 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | 2 | 2 | ||||||||
MIRT508466 | HOXB6 | homeobox B6 | 2 | 4 | ||||||||
MIRT512373 | CPM | carboxypeptidase M | 2 | 2 | ||||||||
MIRT513578 | EVX1 | even-skipped homeobox 1 | 2 | 2 | ||||||||
MIRT517763 | ZNF366 | zinc finger protein 366 | 2 | 4 | ||||||||
MIRT519773 | ZNF354B | zinc finger protein 354B | 2 | 8 | ||||||||
MIRT523568 | GGCX | gamma-glutamyl carboxylase | 2 | 4 | ||||||||
MIRT532802 | CLDN11 | claudin 11 | 2 | 2 | ||||||||
MIRT544299 | TSPYL1 | TSPY like 1 | 2 | 2 | ||||||||
MIRT544862 | MYH2 | myosin heavy chain 2 | 2 | 4 | ||||||||
MIRT556731 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT564347 | AKR1B10 | aldo-keto reductase family 1 member B10 | 2 | 2 | ||||||||
MIRT568924 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | 2 | 2 | ||||||||
MIRT569012 | CXorf36 | chromosome X open reading frame 36 | 2 | 2 | ||||||||
MIRT569256 | FAM129B | family with sequence similarity 129 member B | 2 | 2 | ||||||||
MIRT569591 | PRELP | proline and arginine rich end leucine rich repeat protein | 2 | 2 | ||||||||
MIRT569779 | SAMD14 | sterile alpha motif domain containing 14 | 2 | 2 | ||||||||
MIRT570034 | FAM228A | family with sequence similarity 228 member A | 2 | 2 | ||||||||
MIRT573803 | FRMPD4 | FERM and PDZ domain containing 4 | 2 | 2 | ||||||||
MIRT574190 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT576153 | Hmox1 | heme oxygenase 1 | 2 | 2 | ||||||||
MIRT611311 | CA8 | carbonic anhydrase 8 | 2 | 4 | ||||||||
MIRT673429 | APAF1 | apoptotic peptidase activating factor 1 | 2 | 2 | ||||||||
MIRT674976 | SH3BP2 | SH3 domain binding protein 2 | 2 | 2 | ||||||||
MIRT692712 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|